Eisai news

9 October 2025
Merck Showcases Oncology Advances at ESMO 2025
Merck presents positive data on KEYTRUDA and other investigational medicines for various cancers, highlighting progress in treatment and research at ESMO 2025.

What's Eisai up to in Europe?

Find out with chemXplore Analytics